Cargando…
You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review
RATIONALE: Pancreatic mucoepidermoid carcinoma (MEC) is a rare disease with no more than 10 cases reported in literature. The prognosis is poor and few patients can survival more than 1 year. PATIENT CONCERNS: We presented a case of patient manifested as left upper abdominal pain. Computed tomograph...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882400/ https://www.ncbi.nlm.nih.gov/pubmed/29538223 http://dx.doi.org/10.1097/MD.0000000000009990 |
_version_ | 1783311461381046272 |
---|---|
author | Hu, Hai-Jie Zhou, Rong-Xing Liu, Fei Wang, Jun-Ke Li, Fu-Yu |
author_facet | Hu, Hai-Jie Zhou, Rong-Xing Liu, Fei Wang, Jun-Ke Li, Fu-Yu |
author_sort | Hu, Hai-Jie |
collection | PubMed |
description | RATIONALE: Pancreatic mucoepidermoid carcinoma (MEC) is a rare disease with no more than 10 cases reported in literature. The prognosis is poor and few patients can survival more than 1 year. PATIENT CONCERNS: We presented a case of patient manifested as left upper abdominal pain. Computed tomography demonstrated a low-density shadow measuring 2.1 × 2.4 cm situated at the transition area of neck and body of the pancreas with obscure boundary and irregular enhancement. The preoperative symptoms and imaging features were unspecific. DIAGNOSES: Pancreatic MEC. INTERVENTIONS: Curative surgery of distal pancreatectomy was conducted. Postoperatively, the patient subsequently underwent 8 cycles of chemotherapy using cisplatin (25 mg/m(2)) on day 1 to day 3; and gemcitabine (1000 mg/m(2)) on day 1 and day 8, repeated every 21 days. OUTCOMES: The patient was monitored on a regular basis at our outpatient department and survived 23 months after surgery. LESSONS: Preoperative diagnosis of pancreatic MEC is difficult. Patients with pancreatic MEC may have a survival benefit from the multimodal treatment of curative surgery combined with chemotherapy. |
format | Online Article Text |
id | pubmed-5882400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-58824002018-04-11 You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review Hu, Hai-Jie Zhou, Rong-Xing Liu, Fei Wang, Jun-Ke Li, Fu-Yu Medicine (Baltimore) 7100 RATIONALE: Pancreatic mucoepidermoid carcinoma (MEC) is a rare disease with no more than 10 cases reported in literature. The prognosis is poor and few patients can survival more than 1 year. PATIENT CONCERNS: We presented a case of patient manifested as left upper abdominal pain. Computed tomography demonstrated a low-density shadow measuring 2.1 × 2.4 cm situated at the transition area of neck and body of the pancreas with obscure boundary and irregular enhancement. The preoperative symptoms and imaging features were unspecific. DIAGNOSES: Pancreatic MEC. INTERVENTIONS: Curative surgery of distal pancreatectomy was conducted. Postoperatively, the patient subsequently underwent 8 cycles of chemotherapy using cisplatin (25 mg/m(2)) on day 1 to day 3; and gemcitabine (1000 mg/m(2)) on day 1 and day 8, repeated every 21 days. OUTCOMES: The patient was monitored on a regular basis at our outpatient department and survived 23 months after surgery. LESSONS: Preoperative diagnosis of pancreatic MEC is difficult. Patients with pancreatic MEC may have a survival benefit from the multimodal treatment of curative surgery combined with chemotherapy. Wolters Kluwer Health 2018-03-16 /pmc/articles/PMC5882400/ /pubmed/29538223 http://dx.doi.org/10.1097/MD.0000000000009990 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 7100 Hu, Hai-Jie Zhou, Rong-Xing Liu, Fei Wang, Jun-Ke Li, Fu-Yu You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title | You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title_full | You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title_fullStr | You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title_full_unstemmed | You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title_short | You cannot miss it: Pancreatic mucoepidermoid carcinoma: A case report and literature review |
title_sort | you cannot miss it: pancreatic mucoepidermoid carcinoma: a case report and literature review |
topic | 7100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882400/ https://www.ncbi.nlm.nih.gov/pubmed/29538223 http://dx.doi.org/10.1097/MD.0000000000009990 |
work_keys_str_mv | AT huhaijie youcannotmissitpancreaticmucoepidermoidcarcinomaacasereportandliteraturereview AT zhourongxing youcannotmissitpancreaticmucoepidermoidcarcinomaacasereportandliteraturereview AT liufei youcannotmissitpancreaticmucoepidermoidcarcinomaacasereportandliteraturereview AT wangjunke youcannotmissitpancreaticmucoepidermoidcarcinomaacasereportandliteraturereview AT lifuyu youcannotmissitpancreaticmucoepidermoidcarcinomaacasereportandliteraturereview |